KB
Kishore Babu Turlapati
About Kishore Babu Turlapati
Data last updated:
Kishore Babu Turlapati is a Director at Vickro Biopharma Private Limited (since 2016) and Director at Cognnate Biotech Private Limited (since 2016). The companies operate in Information Technology, Chemicals and Materials and Non-Profit Organizations. The 2 current companies with reported revenue have a combined latest revenue of ₹15.39 Cr; the largest is Vickro Biopharma Private Limited at ₹15.29 Cr (FY 2022). Earlier, Kishore Babu Turlapati was a Director at Kladis Labs India Private Limited (2022–2025) and Director at Sigma-Chi Consulting Private Limited (2016–2021) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vickro Biopharma Private Limited U24304TG2016PTC113121 | Director | 25 Nov 2016 | 2016 | ₹15.29 Cr (FY 2022) | Active |
 Cognnate Biotech Private Limited U24299TG2016PTC112457 | Director | 14 Oct 2016 | 2016 | ₹10.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Kladis Labs India Private Limited U21000TG2022PTC169810 | Director | 29 Dec 2022 | 2022 | Active | |
| Sigma-Chi Consulting Private Limited U24100TG2016PTC112423 | Director | 13 Oct 2016 | 2016 | ₹32.4 Lakh (FY 2025) | Active |
 Gene7 Biotech Private Limited U51497TG2012PTC078357 | Whole-Time Director | 02 Jan 2012 | 2012 | ₹45.4 Lakh (FY 2017) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kishore Babu Turlapati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Indirapriyadarsini Kankanampati | 07435322 | Vickro Biopharma Private Limited , Cognnate Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kishore Babu Turlapati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kishore Babu Turlapati
Kishore Babu Turlapati currently holds 2 directorships: Vickro Biopharma Private Limited (Director, since 25 Nov 2016, revenue ₹15.29 Cr (FY 2022)); Cognnate Biotech Private Limited (Director, since 14 Oct 2016, revenue ₹10.1 Lakh (FY 2025)).
Kishore Babu Turlapati was first appointed on 02 Jan 2012 as Whole-Time Director at Gene7 Biotech Private Limited. The most recent appointment on record is 29 Dec 2022 at Kladis Labs India Private Limited.
The 2 current companies of Kishore Babu Turlapati that report revenue have a combined latest revenue of ₹15.39 Cr: Vickro Biopharma Private Limited ₹15.29 Cr (FY 2022); Cognnate Biotech Private Limited ₹10.1 Lakh (FY 2025).
Kishore Babu Turlapati held 3 earlier board appointments: Kladis Labs India Private Limited (Director, 29 Dec 2022 to 26 Jul 2025); Sigma-Chi Consulting Private Limited (Director, 13 Oct 2016 to 09 Mar 2021); Gene7 Biotech Private Limited (Whole-Time Director, from 02 Jan 2012).
The current boards of Kishore Babu Turlapati's companies include Indirapriyadarsini Kankanampati (Vickro Biopharma Private Limited).